You're invited to join Dicerna’s Investor Day
KOLs and Dicerna management will discuss Dicerna’s key disease areas and development programs, including data from the PHYOX Phase 1 study of DCR-PHXC.
Registration and Details Below
Friday, November 9, 2018
Registration and Breakfast: 8:00 am ET
The St. Regis Hotel